Study: NCT02161354

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NTC-510 capsules
Description: Subjects will be randomized to one of 3 groups and NTC-510 will be given as a single oral dose of 2.0 mg, a split dose of 2.0 mg followed by 2.0 mg an hour later, or 6.0 mg for acute pain relief (PR) following third molar extraction.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NTC-510 capsules
Description: Subjects will be randomized to one of 3 groups and NTC-510 will be given as a single oral dose of 2.0 mg, a split dose of 2.0 mg followed by 2.0 mg an hour later, or 6.0 mg for acute pain relief (PR) following third molar extraction.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NTC-510 capsules
Description: Subjects will be randomized to one of 3 groups and NTC-510 will be given as a single oral dose of 2.0 mg, a split dose of 2.0 mg followed by 2.0 mg an hour later, or 6.0 mg for acute pain relief (PR) following third molar extraction.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NTC-510 capsules
Description: Subjects will be randomized to one of 3 groups and NTC-510 will be given as a single oral dose of 2.0 mg, a split dose of 2.0 mg followed by 2.0 mg an hour later, or 6.0 mg for acute pain relief (PR) following third molar extraction.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NTC-510 capsules
Description: Subjects will be randomized to one of 3 groups and NTC-510 will be given as a single oral dose of 2.0 mg, a split dose of 2.0 mg followed by 2.0 mg an hour later, or 6.0 mg for acute pain relief (PR) following third molar extraction.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NTC-510 capsules
Description: Subjects will be randomized to one of 3 groups and NTC-510 will be given as a single oral dose of 2.0 mg, a split dose of 2.0 mg followed by 2.0 mg an hour later, or 6.0 mg for acute pain relief (PR) following third molar extraction.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo Capsules
Description: Subjects will be randomized to one of 3 groups and placebo capsules will be given as a single oral dose of for acute dental pain following third molar extraction.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo Capsules
Description: Subjects will be randomized to one of 3 groups and placebo capsules will be given as a single oral dose of for acute dental pain following third molar extraction.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo Capsules
Description: Subjects will be randomized to one of 3 groups and placebo capsules will be given as a single oral dose of for acute dental pain following third molar extraction.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo Capsules
Description: Subjects will be randomized to one of 3 groups and placebo capsules will be given as a single oral dose of for acute dental pain following third molar extraction.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo Capsules
Description: Subjects will be randomized to one of 3 groups and placebo capsules will be given as a single oral dose of for acute dental pain following third molar extraction.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo Capsules
Description: Subjects will be randomized to one of 3 groups and placebo capsules will be given as a single oral dose of for acute dental pain following third molar extraction.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NTC-510A Capsules
Description: Subjects will be randomized to one of 3 groups where NTC-510A or placebo will be given as a single oral dose of 2.0, 4.0, or 6 mg for acute pain relief (PR) following third molar extraction

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NTC-510A Capsules
Description: Subjects will be randomized to one of 3 groups where NTC-510A or placebo will be given as a single oral dose of 2.0, 4.0, or 6 mg for acute pain relief (PR) following third molar extraction

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NTC-510A Capsules
Description: Subjects will be randomized to one of 3 groups where NTC-510A or placebo will be given as a single oral dose of 2.0, 4.0, or 6 mg for acute pain relief (PR) following third molar extraction